Skip to main content

MoneyWorks4Me

Wockhardt informs about press release

16 Aug 2022 Evaluate

Wockhardt has informed that it enclosed the Press Release titled ‘Wockhardt announces successful initiation of Global Phase 3 Clinical Study of its novel antibiotic WCK 5222’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1880.90
Dr. Reddys Labs. 1377.00
Cipla 1393.00
Lupin 1980.00
Zydus Lifesciences 1191.00
View more..